ALLIANCEBERNSTEIN L.P. - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$350,244
-28.3%
18,8000.0%0.00%
Q2 2023$488,424
-9.5%
18,8000.0%0.00%
Q1 2023$539,936
-13.0%
18,800
-10.3%
0.00%
Q4 2022$620,298
+31.4%
20,956
+5.6%
0.00%
Q3 2022$472,000
+6.8%
19,841
+0.1%
0.00%
Q2 2022$442,000
-11.1%
19,815
+0.2%
0.00%
Q1 2022$497,000
-29.8%
19,779
+0.1%
0.00%
Q4 2021$708,000
-15.5%
19,758
+0.3%
0.00%
Q3 2021$838,000
-5.0%
19,700
-3.3%
0.00%
Q2 2021$882,000
-7.1%
20,380
-12.4%
0.00%
Q1 2021$949,000
+5.1%
23,258
+16.6%
0.00%
Q4 2020$903,000
+12.6%
19,950
-11.9%
0.00%
Q3 2020$802,000
-6.0%
22,650
+0.1%
0.00%
-100.0%
Q2 2020$853,000
+30.0%
22,620
-0.4%
0.00%
Q1 2020$656,000
-44.1%
22,700
+0.2%
0.00%
-100.0%
Q4 2019$1,174,000
-4.7%
22,650
+0.9%
0.00%0.0%
Q3 2019$1,232,000
+17.6%
22,450
-13.0%
0.00%0.0%
Q2 2019$1,048,000
+62.0%
25,800
+20.6%
0.00%
Q1 2019$647,000
-10.0%
21,4000.0%0.00%
-100.0%
Q4 2018$719,000
-20.4%
21,4000.0%0.00%0.0%
Q3 2018$903,000
+31.8%
21,4000.0%0.00%
Q2 2018$685,000
-22.6%
21,400
+20.2%
0.00%
-100.0%
Q1 2018$885,000
-7.8%
17,8000.0%0.00%0.0%
Q4 2017$960,000
-7.0%
17,8000.0%0.00%0.0%
Q3 2017$1,032,000
+17.5%
17,8000.0%0.00%0.0%
Q2 2017$878,000
+13.6%
17,8000.0%0.00%0.0%
Q1 2017$773,000
-14.7%
17,800
-3.8%
0.00%0.0%
Q4 2016$906,000
+2.4%
18,5000.0%0.00%0.0%
Q3 2016$885,000
-58.6%
18,500
-53.6%
0.00%
-50.0%
Q2 2016$2,137,000
+89.1%
39,830
+57.7%
0.00%
+100.0%
Q1 2016$1,130,000
+47.3%
25,260
+25.6%
0.00%0.0%
Q4 2015$767,000
+20.8%
20,110
+0.9%
0.00%0.0%
Q3 2015$635,000
-3.3%
19,938
+0.2%
0.00%0.0%
Q2 2015$657,000
-19.8%
19,9000.0%0.00%0.0%
Q1 2015$819,000
+1.0%
19,9000.0%0.00%0.0%
Q4 2014$811,000
+11.1%
19,9000.0%0.00%0.0%
Q3 2014$730,000
-20.8%
19,9000.0%0.00%0.0%
Q2 2014$922,000
+198.4%
19,900
+164.3%
0.00%
Q1 2014$309,000
+143.3%
7,529
+126.2%
0.00%
Q4 2013$127,000
+126.8%
3,329
+42.9%
0.00%
Q3 2013$56,000
-6.7%
2,329
-34.3%
0.00%
Q2 2013$60,0003,5450.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders